1. Neuronal Signaling
  2. OGA
  3. O-GlcNAcase-IN-6

O-GlcNAcase-IN-6 是一种口服有效的、可穿过血脑屏障的 O-GlcNAcase (OGA) 抑制剂,其 IC50 为 5.4 nM。O-GlcNAcase-IN-6 可抑制 OGA 活性,进而导致脑组织中 O-GlcNAc 糖基化水平升高。O-GlcNAcase-IN-6 可用于阿尔茨海默病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

O-GlcNAcase-IN-6

O-GlcNAcase-IN-6 Chemical Structure

CAS No. : 2407072-65-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

O-GlcNAcase-IN-6 is an orally active, blood-brain barrier-permeable O-GlcNAcase (OGA) inhibitor with an IC50 of 5.4 nM. O-GlcNAcase-IN-6 inhibits OGA activity, thereby increasing the level of O-GlcNAc glycosylation in brain tissues. O-GlcNAcase-IN-6 can be used for the research of Alzheimer's disease[1].

体外研究
(In Vitro)

O-GlcNAcase-IN-6 (Compound 24) 可通过直接结合酶的活性位点强效抑制人源 OGA,其 IC50 为 5.4 nM[1]
O-GlcNAcase-IN-6 可抑制 HEK293 细胞中的 OGA 活性,其 IC50 为 26 nM[1]
O-GlcNAcase-IN-6 具有较低的体外 MDR1-MDCK 通透性,为 0.7 × 10-6 cm/s,PgP 外排率较高 (> 28),游离血浆蛋白结合率为 0.61,游离脑组织结合率为 0.24[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route C0 T1/2 Vdss CL AUC0-inf Cmax Tmax Bioavailability
Mice[1] 1 mg/kg i.v. 794 ng/mL 1.02 h 2.1 L/kg 50 mL/min/kg 338 ng·h/mL / / /
Mice[1] 5 mg/kg p.o. / 1.7 h / / 1793 ng·h/mL 697 ng/mL 0.5 h 100 %
体内研究
(In Vivo)

O-GlcNAcase-IN-6 (Compound 24) (100 mg/kg;口服;单次给药) 可使雄性 CD1 小鼠脑内 O-GlcNAcylation 水平短暂且显著升高,证实其在体内与 OGA 靶点结合[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: CD1 mice (male)[1]
Dosage: 100 mg/kg
Administration: p.o.; single dose
Result: Induced a transient elevation of brain O-GlcNAcylation levels, peaking at 8 hours post-administration.
Reached a peak increase similar to the 3-3.5-fold increase observed with the reference compound Thiamet-G (500 mg/kg).
Showed measurable brain exposure, with an AUC(brain)/AUC(plasma) ratio of 0.16 and an unbound brain-to-plasma partition coefficient (Kp,uu) of 0.07.
分子量

351.45

Formula

C20H25N5O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
O-GlcNAcase-IN-6
目录号:
HY-183557
需求量: